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Purpose: The objective of this study was, first, to assess the knowledge, attitude and practice of 
commercial drivers in Dar es Salaam with regard to medicines that impair driving, and second, to 
evaluate the adequacy of antihistamine label information.  
Methods: Drivers were interviewed using a questionnaire after obtaining their informed consent. Labels 
of medicines containing antihistamines were also evaluated for information regarding driving.  
Results: Fifty one percent (n=303) of drivers were not aware of medicines that impair driving. Out of 
those who used medicines impairing driving, 56.1% were not given precaution on the impairing effect of 
these medications by healthcare providers. Fifty two percent of the drivers did not know what to do when 
affected; 29.8% said they would continue driving while 16.2% would suspend driving. Drowsiness, 
fatigue and blurred vision were mentioned as the main effects that impaired driving. Cough syrups 
(64.7%), antimalarials (49.5%) and analgesics (28.7%) were mentioned most as medicines affecting 
driving. Labels on products containing equal concentrations of antihistamines revealed inconsistency in 
driving information with some products having cautionary information on driving while others had none. 
Conclusion: This study showed that most of the drivers interviewed had taken medications which 
impaired their driving but did not know what to do. These drivers were not well informed about the 
effects of these medicines on driving. There is need, therefore, to inform the public about medications 
that impair driving. This may help in reducing road traffic accidents which are on the increase since one 
of the causal factors may be the intake of such medicines.   
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INTRODUCTION 
 
Driving is a psychomotor activity that requires 
a combination of concentration and good 
visual and auditory functions.  Several factors 
can affect driving including the use of alcohol 
and certain medications. 
 
The effect of alcohol on driving is well 
known
1,2
. Most drivers are at least aware that 
it is dangerous to drink and drive and in many 
countries driving while drunk is illegal
2
.
   
The effect of medicines on driving on the 
other hand is not well known to the public and 
to drivers in particular. Several studies have 
shown that a variety of medicines when taken 
can affect the mental and physical skills 
needed for safe driving. Some of these 
medicines include antihistamines which are 







Others include antimalarials, for example, 
Sulphadoxine/Pyrimethamine (SP) which 
cause tiredness and depression, quinine and 
chloroquine which impair vision and hearing 
respectively
7
. When medicines affecting 
driving are being prescribed and or 
dispensed, it is always assumed that medical 
personnel will give all the necessary 
information and instructions to the patient. 
Studies however, have shown that actually 
counseling of patients on medications is not 





In case of over the counter 
drugs, it is assumed that the patient will read 
the label containing a warning on driving and 
follow the instructions properly. Studies, 
however, have shown that patients do not 
often read labels on medicine packages and 
even if they read sometimes, they do not 
understand
10
. At times the warnings are 
ambiguous. Users of most of these medicines 
are ambulatory patients who can drive a car. 
This puts them at risk if proper instructions or 
warning are not provided by the health 
workers in particular dispensers of medicines 
in pharmacies.  
In Tanzania, to the best of our knowledge, no 
studies that have been undertaken to assess 
medicine use and driving. 
 
This work therefore was carried out to assess 
the knowledge, attitudes and practice of 
commercial drivers in Dar es Salaam Region 
regarding medicines impairing driving. The 
study also investigated whether drivers obtain 
information and warning from 
prescribers/dispensers about the driving 
impairment effect of medicines. In addition 
the study evaluated the adequacy of 




      This was a cross sectional study which 
involved the following drivers in Dar es 
Salaam region; drivers of commuter buses 
known as ‘dala dala’ within Dar es Salaam 
city, taxi drivers, long distance lorry drivers 
and inter- regional bus drivers. Drivers from 
each of the above categories were 
interviewed face to face using questionnaire 
after obtaining a verbal consent from the 
individual driver. The questionnaire was 
developed and pre-tested in 15 drivers. 
Drivers to be interviewed were selected 
randomly at their packing stations 
 
Ethical clearance for the study was obtained 
from the School of Pharmacy Research 
Committee, a subcommittee of Muhimbili 
University of Health and Allied Sciences      
(MUHAS) Research and Publication 
Committee, which has the mandate for 
granting ethical approval. Permission to 
interview drivers was obtained from the 
Drivers’ Association in Dar es Salaam. 
                 
Data analysis was carried out using Epi Info 




Three hundred and three drivers (303) out of 
384 drivers approached for the study agreed 
to participate. All 303 drivers interviewed 
were males (Table 1). Forty two percent were 
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in the age range of 36-45 years. Their driving 
experience was from 2 to more than 10 years 
with most drivers (63%) having more than six 
years of experience. Fifty one percent 
(51.5%) of drivers were unaware of the 
existence of medicines that impair driving. 
Table 2 shows medicines that impair driving 
as mentioned by drivers. Cough medications 
were high on the list (64.7%).  
 






Age (years)  
<20 2 (0.7) 
20 – 25 42 (13.9) 
26 – 35 79 (26.0) 
36 – 45 126 (41.6) 
> 45 26 (8.6) 
No response 28 (9.2) 
Education Level  
Primary Education 121 (39.9) 
O- Level 80 (26.4) 
A- Level 20 (6.6) 
College level 38 (12.5) 
No response 44 (14.5) 
 
Table 2: Medicines affecting driving as mentioned 
by drivers (n=303)  
 
Medication Frequency (%) 
Cough syrups 196 (64.7) 
Anti malaria drugs 150 (49.5) 
Medicines used for 
colds 
66 (21.8) 
Antihypertensive 21 (6.9) 
Hypnotics 37 (12.2) 
Pain killers 87 (28.7) 
Antiepileptic 2 (0.7) 
 
Regarding the effects that impaired driving 
drowsiness (72%) due to medications was 
mentioned by many drivers. Forty one 
percent mentioned fatigue as one of the 
effects impairing driving while 12% 
mentioned blurred vision. Table 3 shows the 
type of side effects experienced most and the 
type of medications taken. For cough syrups, 
drowsiness (38%) was common while with 
antimalarials fatigue (36%) was the main 
effect felt. When asked whether they read 
labels of medications. Sixty eight percent of 
drivers said they read labels on containers of 
medicines. Forty two percent (42%) of the 
drivers read labels in order to get information 
on how to use the medication, while 42% 
looked out for a warning and about 4% 
looked out for the content.  Most drivers 
(52%) said they did not know what to do 
when affected by medication-impaired 
driving. 
 
Analysis of information on labels of different 
brands of medications for cough and colds, 
revealed that brands with the same 
concentration of the active ingredient 
affecting driving had different 
instructions/warnings on driving. Some 
products carried the warning while others of 
the same concentration did not. The products 
examined contained the same antihistamines 
of the same strength (Table 4). 
 
Table 3: Side effects experienced by those who 




Frequency (%)  
n=196) 
Antimalarials  
Frequency (%)  
n = 150       
Drowsiness 75 (38.3) - 
Dizziness 8 (4.1) 8 (5.3) 
Fatigue 45 (23.0) 54 (36.0) 
Itching 2 (1.0) 5 (3.3) 
Sedation 6 (3.0) - 
Blurred vision - 25 (16.7) 





Use of medicines that impair driving was 
reported among the population of drivers 
studied. Drivers who were aware of the 
existence of medicines that impair driving had 
this knowledge from experience, i.e., they 
had used the medicines and they were 
affected. 
 
Cough syrups were the most mentioned 
drugs. Some drivers were able to mention 
specific  brands of  cough  syrups all of which  
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Table 4: Information on labels of containers of medicines containing antihistamine 
 
Strength  Number of product brand  Label information 




Warning on driving  
 
2mg 3 No warning 
Diphenhydramine  
25 mg 3 
14 mg 4 
12 mg 3 
8 mg 1 
7 mg 1 
2.2 mg 2 
Warning on driving 
14 mg 4 
5 mg 2 
No warning 
Promethazine 
5 mg 3 Warning on driving 
5mg  2 No warning 
 
were found to contain antihistamines on their 
labels. This finding is in agreement with other 
studies which have tested the effects of 
antihistamine on driving performance 
3
. Use of 
sedating medicines has also been shown to 
be a risk factor in drowsy -driving crash
11
. The 
results for medicines said to affect driving are 
similar to the findings of McGwin et al who 
showed that non-steroidal anti-inflammatory 
drugs, benzodiazepines and angiotensin 
converting enzyme inhibitors were associated 
with increased risk of ‘at fault’ involvement in 
vehicle crashes
12
. In our study, nearly three 
out of ten of the drivers mentioned analgesics 
as causing driving impairment. The 
psychotropic effect of analgesics has also 





With regard to adverse effects following 
medications, drowsiness was the most 
mentioned effect and fatigue was next.  These 
two have been classified as behavior factors 
that can reduce capability to drive on a short 
term basis and therefore cause road traffic 
crashes
14
. Different therapeutic groups of 
medicines had different adverse effects that 
impaired driving most. For cough syrups, the 
most mentioned effect was drowsiness 
(38.3%). This may be due to the fact that most 
of these cough medicines contained 
antihistamines which have been shown to 
cause sedation. For antimalarials, the most 
mentioned effect was fatigue and blurred 
vision and among medicines mentioned were 
quinine and chloroquine. These two drugs 





Only a few of the drivers admitted to have 
received warnings from dispensers about 
effects of medicines on driving. About half 
said that they had never been warned on the 
effects of medicines on driving. This suggests 
that prescribers/dispensers do not give 
adequate medication information to patients. 
Prescribing guidelines laid down by 
International Pharmaceutical Federation 
(FIP)
15 
state that if the drug is known to impair 
performance, then it is better to look for 
alternatives. If no alternative is possible then 
the patient must be advised accordingly. 
According to the present results patients were 
not advised on driving impairment of these 
medications. Similar results were shown in a 
study done by Brooke et al
16 
where patients 
were not informed about their fitness to drive. 
It may be assumed that the 
prescribers/dispensers were not aware of the 
dangers involved and hence the need to 
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inform the patient. A study by Kelly et al
17
 
showed that doctors’ knowledge on driving 
restrictions and actions to be taken if a patient 
was not fit to drive was very poor. 
 
Less than half of the drivers said that they 
read the labels but they only looked out for 
instructions on how to use the medication. 
Some looked out for warning but could not tell 
what the warning was against, while several 
others did not bother reading labels. This puts 
the drivers at risk especially when they obtain 
over-the-counter (OTC) medicines  
 
Half of the drivers did not know what to do 
when they took medicines that affect driving. 
This shows that these drivers were not 
informed and that can be dangerous if the 
driver decided to engage in driving while 
under the influence of these medications. 
The fact that there was a great variation in the 
display of warning information is of great 
concern. Wrong labeling can cause problems 
to the user, in this case the driver who may 




Medicines that affect driving are a problem to 
the society. Road traffic accidents are on the 
increase in Tanzania and one of the causal 
factors may be the intake of medicines that 
impair driving. This study has shown that most 
of the drivers interviewed had taken 
medication that could have affected their 
driving but did not know what to do when the 
medication affected adversely. This indicates 
that drivers were not well informed about the 
effects of these medicines and the actions to 
be taken. There is a need therefore to inform 
the public and raise awareness about 
medications impairing driving. Proper labeling 
of medicines affecting driving is needed in 
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